Hemostemix Inc (HEM : TSX-V)
Common Stock
$0.07
CAD
+0.00 (%)
Last updated: 2026-07-20
HEM
Hemostemix Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+8.33%
1 Month
+30.00%
YTD
-27.78%
Key Statistics
Market Cap
$12.30M
52W High
$0.14
52W Low
$0.04
P/E Ratio
-
50 Day MA
$0.06
200 Day MA
$0.08
Beta
0.62
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/20/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 31,911 |
| 7/17/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 33,911 |
| 7/16/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 34,029 |
| 7/15/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 131,911 |
| 7/13/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 2,411 |
| 7/9/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 28,835 |
| 7/8/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 81,000 |
| 7/7/2026 | $0.05 | $0.05 | $0.04 | $0.04 | $0.04 | 29,000 |
| 7/6/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 1,650 |
| 7/3/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 1,000 |
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1376.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1376.9% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
136.1%
Annualized
90-Day Vol
109.7%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 โ C$0.10 |
| 60 trading days | C$0.06 | C$0.03 โ C$0.13 |
| 90 trading days | C$0.06 | C$0.03 โ C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Hemostemix Inc
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-4.88M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.02
- Book Value
- -0.03
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About HEM
Articles Featuring HEM.V
Latest articles and analysis covering HEM.V
Why Hemostemix Inc stock is plummeting today
Hemostemix Inc. (HEM.V) experienced a sharp decline in its stock price today, closing at CA$0.06 after a 7.69% drop. The company's reliance on private placements and lack of recent positive news may be contributing factors to this downturn.
Why Hemostemix Inc stock is skyrocketing today
Hemostemix Inc's stock soared by 7.69% in the last trading session, closing at CA$0.07. This surge comes in light of the company's recent financing activities aimed at advancing its clinical initiatives.
Why Hemostemix Inc stock is skyrocketing today
Hemostemix Inc stock has skyrocketed by 8.33% today, closing at CA$0.07. This surge reflects growing investor interest in the company's potential developments in the stem cell therapy market.
Why Hemostemix Inc stock is skyrocketing today
Hemostemix Inc (HEM.V) has seen its stock price soar by 33.33% in the latest trading session, closing at CA$0.06. This remarkable increase highlights the potential investor interest in the company's innovative approaches to stem cell therapies.
Why Hemostemix Inc stock is plummeting today
Hemostemix Inc. has seen a drastic 18.18% drop in its stock price today, highlighting investor concerns over the company's reliance on private placements and lack of substantial operational updates.
Why Hemostemix Inc stock is plummeting today
Hemostemix Inc's stock plummeted by 9.09% in the last trading session, closing at CA$0.05. This decline raises questions about the company's financial health and future prospects, especially in light of its recent fundraising efforts.
